Login / Signup

Feasibility of intranasal human milk as stem cell therapy in preterm infants with intraventricular hemorrhage.

Rebecca HobanAlessia GallipoliMarisa SignorilePoonam ManderAndree Gauthier-FisherClifford LibrachDiane WilsonSharon L Unger
Published in: Journal of perinatology : official journal of the California Perinatal Association (2024)
This phase 1 study demonstrated IPOM was tolerated and feasible in preterm infants.
Keyphrases
  • preterm infants
  • low birth weight
  • human milk
  • stem cells
  • open label
  • preterm birth
  • cell therapy
  • clinical trial
  • double blind
  • placebo controlled
  • study protocol
  • chemotherapy induced